It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The interplay between 3D chromatin architecture and gene silencing is incompletely understood. Here, we report a novel point mutation in the non-canonical SMC protein SMCHD1 that enhances its silencing capacity at endogenous developmental targets. Moreover, it also results in enhanced silencing at the facioscapulohumeral muscular dystrophy associated macrosatellite-array, D4Z4, resulting in enhanced repression of DUX4 encoded by this repeat. Heightened SMCHD1 silencing perturbs developmental Hox gene activation, causing a homeotic transformation in mice. Paradoxically, the mutant SMCHD1 appears to enhance insulation against other epigenetic regulators, including PRC2 and CTCF, while depleting long range chromatin interactions akin to what is observed in the absence of SMCHD1. These data suggest that SMCHD1’s role in long range chromatin interactions is not directly linked to gene silencing or insulating the chromatin, refining the model for how the different levels of SMCHD1-mediated chromatin regulation interact to bring about gene silencing in normal development and disease.
Here the authors reveal that a neomorphic mutation in chromatin protein SMCHD1 enhances SMCHD1-mediated gene silencing, including at the FSHD disease-relevant locus, while depleting SMCHD1-mediated chromatin interactions, suggesting these SMCHD1 functions are unlinked.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
















1 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889); University of Melbourne, The Department of Medical Biology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
2 Leiden University Medical Center, Department of Human Genetics, Leiden, Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978)
3 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889)
4 The Francis Crick Institute, Crick Advanced Light Microscopy Facility, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
5 Queensland Institute of Medical Research, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395)
6 National University of Singapore, Department of Biological Sciences, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243)
7 Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243); Genome Institute of Singapore, A*STAR, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X)
8 Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Australian Regenerative Medicine Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
9 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889); University of Melbourne, The Department of Medical Biology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Monash University, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)